- In September 2024, Agilent Technologies completed the acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization specializing in biologics and highly potent active pharmaceutical ingredients. This strategic move enhances Agilent's Diagnostics and Genomics Group by expanding its contract development and manufacturing organization (CDMO) services, particularly in gene editing and targeted therapeutics. The acquisition strengthens Agilent's capabilities in cGMP pharmaceutical manufacturing, aligning with the growing demand for advanced therapeutics. This development is expected to bolster Agilent's position in the pharmaceutical market by offering comprehensive solutions that accelerate therapeutic programs
- In July 2021, Francisco Partners, a global investment firm specializing in technology businesses, announced the acquisition of the STARLIMS informatics product suite and related business assets from Abbott Laboratories. This strategic move aims to enhance STARLIMS's capabilities in laboratory data and workflow management across various sectors, including life sciences, pharmaceuticals, and manufacturing. The acquisition is expected to accelerate STARLIMS's growth by supporting customers throughout the entire product lifecycle, from research and development to manufacturing and compliance. Francisco Partners plans to leverage its sectoral knowledge and operational expertise to further evolve STARLIMS's innovative product suite, meeting the evolving needs of its customers while maintaining industry-leading safety and compliance standards
- In July 2021, Francisco Partners, a global investment firm specializing in technology businesses, acquired the STARLIMS informatics product suite and related business assets from Abbott Laboratories. This acquisition aims to enhance STARLIMS's capabilities in laboratory data and workflow management across various sectors, including life sciences, pharmaceuticals, and manufacturing. The move is expected to support STARLIMS's growth by providing comprehensive solutions that span the entire product lifecycle, from research and development to manufacturing and compliance. Francisco Partners plans to leverage its sectoral knowledge and operational expertise to further evolve STARLIMS's innovative product suite, meeting the evolving needs of its customers while maintaining industry-leading safety and compliance standards
